Literature DB >> 18615013

Polo-like kinase-1 is activated by aurora A to promote checkpoint recovery.

Libor Macůrek1, Arne Lindqvist, Dan Lim, Michael A Lampson, Rob Klompmaker, Raimundo Freire, Christophe Clouin, Stephen S Taylor, Michael B Yaffe, René H Medema.   

Abstract

Polo-like kinase-1 (PLK1) is an essential mitotic kinase regulating multiple aspects of the cell division process. Activation of PLK1 requires phosphorylation of a conserved threonine residue (Thr 210) in the T-loop of the PLK1 kinase domain, but the kinase responsible for this has not yet been affirmatively identified. Here we show that in human cells PLK1 activation occurs several hours before entry into mitosis, and requires aurora A (AURKA, also known as STK6)-dependent phosphorylation of Thr 210. We find that aurora A can directly phosphorylate PLK1 on Thr 210, and that activity of aurora A towards PLK1 is greatly enhanced by Bora (also known as C13orf34 and FLJ22624), a known cofactor for aurora A (ref. 7). We show that Bora/aurora-A-dependent phosphorylation is a prerequisite for PLK1 to promote mitotic entry after a checkpoint-dependent arrest. Importantly, expression of a PLK1-T210D phospho-mimicking mutant partially overcomes the requirement for aurora A in checkpoint recovery. Taken together, these data demonstrate that the initial activation of PLK1 is a primary function of aurora A.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18615013     DOI: 10.1038/nature07185

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  337 in total

Review 1.  Functions and regulation of the Polo-like kinase Cdc5 in the absence and presence of DNA damage.

Authors:  Vladimir V Botchkarev; James E Haber
Journal:  Curr Genet       Date:  2017-08-02       Impact factor: 3.886

Review 2.  Prophase I arrest and progression to metaphase I in mouse oocytes: comparison of resumption of meiosis and recovery from G2-arrest in somatic cells.

Authors:  Petr Solc; Richard M Schultz; Jan Motlik
Journal:  Mol Hum Reprod       Date:  2010-05-07       Impact factor: 4.025

3.  Radiation pharmacogenomics: a genome-wide association approach to identify radiation response biomarkers using human lymphoblastoid cell lines.

Authors:  Nifang Niu; Yuxin Qin; Brooke L Fridley; Junmei Hou; Krishna R Kalari; Minjia Zhu; Tse-Yu Wu; Gregory D Jenkins; Anthony Batzler; Liewei Wang
Journal:  Genome Res       Date:  2010-10-05       Impact factor: 9.043

4.  Phosphorylation and dephosphorylation events allow for rapid segregation of fate determinants during Drosophila neuroblast asymmetric divisions.

Authors:  Rita Sousa-Nunes; Wayne Gregory Somers
Journal:  Commun Integr Biol       Date:  2010-01

Review 5.  The Renaissance or the cuckoo clock.

Authors:  Jonathon Pines; Iain Hagan
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-12-27       Impact factor: 6.237

6.  Monitoring kinase and phosphatase activities through the cell cycle by ratiometric FRET.

Authors:  Elvira Hukasova; Helena Silva Cascales; Shravan R Kumar; Arne Lindqvist
Journal:  J Vis Exp       Date:  2012-01-27       Impact factor: 1.355

7.  Chromatin regulators and their impact on DNA repair and G2 checkpoint recovery.

Authors:  Veronique A J Smits; Ignacio Alonso-de Vega; Daniël O Warmerdam
Journal:  Cell Cycle       Date:  2020-07-30       Impact factor: 4.534

8.  Plk1 Phosphorylation of Mre11 Antagonizes the DNA Damage Response.

Authors:  Zhiguo Li; Jie Li; Yifan Kong; Shan Yan; Nihal Ahmad; Xiaoqi Liu
Journal:  Cancer Res       Date:  2017-05-16       Impact factor: 12.701

9.  RNAi screen identifies a synthetic lethal interaction between PIM1 overexpression and PLK1 inhibition.

Authors:  Riet van der Meer; Ha Yong Song; Seong-Hoon Park; Sarki A Abdulkadir; Meejeon Roh
Journal:  Clin Cancer Res       Date:  2014-04-25       Impact factor: 12.531

10.  Cyclin B2 and p53 control proper timing of centrosome separation.

Authors:  Hyun-Ja Nam; Jan M van Deursen
Journal:  Nat Cell Biol       Date:  2014-04-28       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.